Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Nessan Bermingham currently holds 14,677 shares of Intellia Therapeutics, Inc. (NTLA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Nessan Bermingham has been a net seller of NTLA stock. They have purchased $0 and sold $7.0M worth of shares.
Nessan Bermingham's most recent insider trade was on Jun 10, 2026, when they sold 14,677 shares at $0.00 per share.
Nessan Bermingham serves as Executive at Intellia Therapeutics, Inc. (NTLA). They have executed 14 insider transactions totaling $7.0M over their tenure at the company.
Nessan Bermingham holds the position of Executive at Intellia Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 10 years and currently hold a stake valued at $0.
Nessan Bermingham has shown a selling trading pattern, with $0 in total purchases and $7.0M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Nessan Bermingham was on Dec 7, 2017, when they sold $2.2M worth of NTLA shares. This transaction involved 103,574 shares at $21.05 per share.
Nessan Bermingham currently owns 14,677 shares of Intellia Therapeutics, Inc. (NTLA), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Nessan Bermingham's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Nessan Bermingham has 14 Form 4 filings on record as an insider at Intellia Therapeutics, Inc..
Set alerts for Nessan Bermingham and 40,000+ other insiders.